The question of how much control the president has over independent agencies like the Consumer Product Safety Commission has erupted repeatedly in the first months of Trump’s administration.
Insurance “nonrenewal” rates have been climbing nationwide. They’ve hit climate-sensitive areas including Florida, Louisiana, North Carolina and California.
Pro-Palestinian student groups are calling for “divestment” from the Israeli war effort. But little is known about the $850 billion in U.S. college endowments.
Cities are frustrated by 911 calls from senior facilities to help residents off the floor or toilet. Some are now charging fees, but facilities keep calling.
Haley, Trump’s main competitor, acknowledged that the pledge was a requirement to participate in RNC debates but added that the party has changed since then.
Access to Narcan, a lifesaving drug that reverses overdoses, has been limited by Emergent BioSolutions’ hunt for profits, including a five-year delay in bringing it over the counter.
The AR-15 wasn’t supposed to be a best-seller. It’s the result of a dramatic shift in American gun culture fueled by the firearms industry and its allies.